Attention Bias Modification for Anxiety in Childhood Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a treatment called Attention Bias Modification (ABM) to reduce anxiety in adolescent and young adult cancer survivors. Anxiety commonly affects these survivors and can lead to depression and sleep issues. ABM involves short, self-guided smartphone tasks to alter reactions to stressors and includes activities to enhance positive emotions. Participants will use either the ABM app or a similar task for four weeks. The trial seeks cancer survivors aged 15-29 who have completed treatment and have smartphone access. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance mental health support for cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Attention Bias Modification is safe for adolescent and young adult cancer survivors?
Research has shown that Attention Bias Modification (ABM) safely helps manage anxiety. In past studies, participants, including children and teens, handled ABM well, with no major reports of harmful side effects. This treatment uses a smartphone app to change reactions to anxiety-inducing stimuli. Participants complete tasks that encourage focus on neutral or positive things instead of negative ones. This method has lowered anxiety symptoms without causing discomfort or adverse effects. Overall, ABM appears to be a safe choice for managing anxiety, even for teens and young adults who have survived cancer.12345
Why are researchers excited about this trial?
Researchers are excited about Attention Bias Modification (ABM) for anxiety in childhood cancer survivors because it offers a novel approach compared to traditional therapies like cognitive-behavioral therapy or medication. ABM specifically targets the way attention is directed, helping patients shift focus away from anxiety-triggering stimuli. Unlike conventional methods that often require longer duration to see results, ABM sessions are brief and supplemented by engaging daily text prompts, potentially leading to quicker and more sustainable improvements in managing anxiety. The use of technology in the form of text messaging also makes this method accessible and easy to integrate into daily life, offering a modern twist to anxiety management.
What evidence suggests that Attention Bias Modification is effective for anxiety in childhood cancer survivors?
Research has shown that Attention Bias Modification (ABM), which participants in this trial may receive, can help reduce anxiety symptoms. Studies have found that children who participated in ABM often experienced a significant reduction in anxiety, with many no longer having an anxiety disorder. ABM helps individuals change their automatic reactions to stress by shifting focus away from threats and towards more neutral or positive thoughts. Using smartphone apps, ABM includes activities like identifying things to be grateful for, which can increase positive feelings. This method aims to improve anxiety symptoms in adolescents and young adults who have survived cancer.12678
Who Is on the Research Team?
Nancy Lau, PhD
Principal Investigator
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for adolescent and young adult cancer survivors who have experienced anxiety after battling childhood cancer, head and neck cancers, or leukemia. Participants should be comfortable using internet-based applications and willing to engage in interviews and questionnaires.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in ABM or inert attention task sessions over 10 minutes twice a week and respond daily to text messaging prompts for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants are given access to all components of ABM and texts on study after completion of the follow-up survey
What Are the Treatments Tested in This Trial?
Interventions
- Attention Bias Modification
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator